| Name | 4-[[(2R)-4-morpholin-4-yl-4-oxo-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)benzenesulfonamide |
|---|
| Molecular Formula | C21H24F3N3O6S3 |
|---|---|
| Molecular Weight | 567.62200 |
| Exact Mass | 567.07800 |
| PSA | 177.93000 |
| LogP | 5.32200 |
|
~86%
1027345-11-4 |
| Literature: ASTRAZENECA AB Patent: US2012/35134 A1, 2012 ; Location in patent: Page/Page column 55; 56 ; |
|
~77%
1027345-11-4 |
| Literature: GENENTECH, INC.; WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH Patent: WO2008/61208 A2, 2008 ; Location in patent: Page/Page column 38 ; WO 2008/061208 A2 |
|
~%
1027345-11-4 |
| Literature: US2012/35134 A1, ; |
|
~%
1027345-11-4 |
| Literature: US2012/35134 A1, ; |
|
~%
1027345-11-4 |
| Literature: US2012/35134 A1, ; |
|
~%
1027345-11-4 |
| Literature: US2012/35134 A1, ; |
|
~%
1027345-11-4 |
| Literature: US2012/35134 A1, ; |
| Precursor 4 | |
|---|---|
| DownStream 1 | |